Briet, Claire
Ilie, Mirela Diana
Kuhn, Emmanuelle
Maione, Luigi
Brailly-Tabard, Sylvie
Salenave, Sylvie
Cariou, Bertrand
Chanson, Philippe http://orcid.org/0000-0001-5096-5722
Funding for this research was provided by:
Fondation Leducq (13CVD03)
Article History
Received: 14 July 2018
Accepted: 17 October 2018
First Online: 5 November 2018
Compliance with ethical standards
:
: Disclosure of potential conflicts of interest: P.C. is a consultant for Novartis, Ipsen, and Pfizer. Honoraria and lecture fees from Novartis, Ipsen, and Pfizer have been paid to his institution. The Service d’Endocrinologie et des Maladies de la Reproduction, Hôpital de Bicêtre, has received educational and research grants from Novartis, Ipsen, and Pfizer. B.C. has received research funding from Pfizer and Sanofi-Regeneron, and honoraria from Amgen, AstraZeneca, Pierre Fabre, Janssen, Eli-Lilly, MSD Merck & Co., Novartis, Novo-Nordisk, Sanofi, and Takeda. All the remaining authors declare that they have no conflict of interest.
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.